LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 78 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2021. The put-call ratio across all filers is 2.29 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,083,000 | +5.3% | 536,847 | +9.3% | 0.03% | -3.3% |
| Q3 2020 | $1,979,000 | +32.2% | 491,141 | +39.8% | 0.03% | +30.4% |
| Q2 2020 | $1,497,000 | -40.8% | 351,425 | -45.4% | 0.02% | -30.3% |
| Q4 2019 | $2,529,000 | +24.5% | 643,444 | +103.7% | 0.03% | +22.2% |
| Q1 2019 | $2,031,000 | -19.3% | 315,910 | +152.7% | 0.03% | -3.6% |
| Q3 2018 | $2,516,000 | +72.4% | 125,000 | +150.0% | 0.03% | +115.4% |
| Q2 2018 | $1,459,000 | +132.3% | 50,000 | +137.2% | 0.01% | +160.0% |
| Q1 2018 | $628,000 | -73.8% | 21,075 | -73.8% | 0.01% | -75.0% |
| Q2 2017 | $2,399,000 | +7.1% | 80,583 | +7.4% | 0.02% | +11.1% |
| Q1 2017 | $2,239,000 | – | 75,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,872,130 | $77,548,000 | 30.77% |
| RTW INVESTMENTS, LP | 1,084,416 | $29,279,000 | 9.67% |
| Avoro Capital Advisors LLC | 784,199 | $21,173,000 | 7.29% |
| Broadfin Capital, LLC | 1,165,373 | $31,465,000 | 1.94% |
| P.A.W. CAPITAL CORP | 50,400 | $1,361,000 | 1.54% |
| Belmont Global Advisors, Inc. | 37,522 | $1,013,000 | 1.31% |
| Perceptive Advisors | 649,515 | $17,537,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 82,920 | $2,239,000 | 1.07% |
| Iguana Healthcare Management, LLC | 110,000 | $2,970,000 | 0.98% |
| Virtus ETF Advisers LLC | 10,250 | $277,000 | 0.76% |